# A Phase I Study of SIM0532 in Adult Participants With Advanced Solid Tumors

> **NCT07749703** · PHASE1 · ACTIVE_NOT_RECRUITING · sponsor: **Jiangsu Simcere Pharmaceutical Co., Ltd.** · enrollment: 346 (estimated)

## Conditions studied

- Histologically or Cytologically Confirmed Advanced Solid Tumors

## Interventions

- **DRUG:** SIM0532 Tablets

## Key facts

- **NCT ID:** NCT07749703
- **Lead sponsor:** Jiangsu Simcere Pharmaceutical Co., Ltd.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** ACTIVE_NOT_RECRUITING
- **Start date:** 2026-03-31
- **Primary completion:** 2028-06-30
- **Final completion:** 2030-06-30
- **Target enrollment:** 346 (ESTIMATED)
- **Last updated:** 2026-08-11

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07749703

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07749703, "A Phase I Study of SIM0532 in Adult Participants With Advanced Solid Tumors". Retrieved via MORVS 2026-10-20 from https://api.morvs.ai/clinical/NCT07749703. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*